Medicare Enrolled

Dr. Kris Kowdley, MD

Gastroenterology · Seattle, WA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
3216 NE 45TH PL STE 212, Seattle, WA 98105
2065363030
In practice since 2006 (19 years)
NPI: 1699850404 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kowdley from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kowdley? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kowdley

Dr. Kris Kowdley is a gastroenterology specialist in Seattle, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kowdley performed 33 Medicare services across 31 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kowdley received a total of $1,204,088 from 41 pharmaceutical and/or device companies across 759 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kowdley is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 33 Medicare services $1,204,088 industry payments

Medicare Practice Summary

Medicare Utilization ↗
33
Medicare services
Bottom 5% in WA for gastroenterology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
31
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Liver stiffness measurement
A non-invasive test that uses ultrasound or similar technology to measure the stiffness of liver tissue. This measurement helps assess the degree of liver fibrosis or scarring.
 33 $25 $100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,204,088
Total received (2018-2024)
Avg $172,013/year across 7 years
Top 1% in WA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
759
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$636,026 (52.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$557,969 (46.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,093 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$235,738
2023
$234,865
2022
$159,946
2021
$109,612
2020
$171,312
2019
$155,248
2018
$137,365

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Gilead Sciences, Inc.
$35,563
Boehringer Ingelheim Pharmaceuticals, Inc.
$35,042
Intercept Pharmaceuticals, Inc.
$32,653
Ipsen Biopharmaceuticals, Inc
$26,622
GlaxoSmithKline, LLC.
$23,525
Madrigal Pharmaceuticals
$22,849
Mirum Pharmaceuticals, Inc.
$14,690
Novo Nordisk Inc
$12,603
Ipsen Bioscience Inc.
$7,470
Merck Sharp & Dohme LLC
$6,710
Kowa Research Institute, Inc.
$6,221
Ipsen Innovation
$3,320
ORPHALAN INC
$3,101
Echosens North America, Inc.
$1,800
Amgen Inc.
$1,800
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$750
Boehringer Ingelheim International GmbH
$735
Corcept Therapeutics
$153
AstraZeneca Pharmaceuticals LP
$132
Top 3 companies account for 43.8% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$324,674
Intercept Pharmaceuticals, Inc.
$234,293
INTERCEPT PHARMACEUTICALS, INC.
$85,538
Novo Nordisk Inc
$72,829
Ipsen Biopharmaceuticals, Inc
$60,802
GlaxoSmithKline, LLC.
$57,097
Mallinckrodt Hospital Products Inc.
$53,415
AbbVie, Inc.
$46,260
Boehringer Ingelheim Pharmaceuticals, Inc.
$46,113
Mirum Pharmaceuticals, Inc.
$28,985
Madrigal Pharmaceuticals
$22,849
Ipsen Innovation
$22,269
Ipsen Bioscience Inc.
$19,677
AbbVie Inc.
$19,452
Alexion Pharmaceuticals, Inc.
$16,911
Ipsen Pharma SAS
$9,545
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$9,361
Kowa Research Institute, Inc.
$9,032
Boehringer Ingelheim International GmbH
$8,226
Merck Sharp & Dohme LLC
$6,710
Merck Sharp & Dohme Corporation
$5,823
ABBVIE INC.
$5,060
Roche Diagnostics International Ltd
$4,800
Allergan Inc.
$4,526
Novo Nordisk AS
$3,375
ALBIREO PHARMA, INC.
$3,290
Ipsen Bioscience Inc
$3,280
ORPHALAN INC
$3,134
Theratechnologies Inc.
$2,031
PFIZER INC.
$1,890
Eisai Inc.
$1,847
Echosens North America, Inc.
$1,800
Amgen Inc.
$1,800
AstraZeneca Pharmaceuticals LP
$1,743
Dova Pharmaceuticals
$1,649
Celgene Corporation
$1,500
Corcept Therapeutics
$1,473
Shionogi Inc
$750
PENTAX of America, Inc.
$151
Eiger BioPharmaceuticals, Inc.
$77
La Jolla Pharmaceutical Company
$54
Top 3 companies account for 53.5% of all-time payments
Associated products mentioned in payments ›
Bylvay · CUVRIOR · Doptelet · EGRIFTA · Epclusa · FibroScan · Harvoni · IQIRVO · Korlym · Lenvima · Livdelzi · Livmarli · MAVYRET · Mavyret · Mulpleta · OCALIVA · Ozempic · RDI Research · RESMETIROM · REZDIFFRA · TERLIVAZ · UPLIZNA · Vemlidy · XIFAXAN · ZOKINVY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (53%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for gastroenterology in WA.

Looking for a gastroenterology specialist in Seattle?
Compare gastroenterologists in the Seattle area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
242
Per 100K population
10.7
County median income
$122,148
Nearest hospital
SEATTLE CHILDREN'S HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kowdley is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of WA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kowdley experienced with liver stiffness measurement?
Based on Medicare claims data, Dr. Kowdley performed 33 liver stiffness measurement services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kowdley receive payments from pharmaceutical companies?
Yes. Dr. Kowdley received a total of $1,204,088 from 41 companies across 759 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kowdley's costs compare to other gastroenterologists in Seattle?
Dr. Kowdley's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kowdley) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Seattle
Browse gastroenterologists in Seattle ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in WA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in WA
Which WA gastroenterologists receive the most from drug and device companies.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Intercept Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Intercept Pharmaceuticals, Inc.
By company
INTERCEPT PHARMACEUTICALS, INC. Payments to Doctors
See all physicians who received payments from INTERCEPT PHARMACEUTICALS, INC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →